These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37850982)

  • 1. Association of Alcohol Consumption With CD4 Recovery After Antiretroviral Therapy Initiation in St. Petersburg, Russia.
    McLaughlin A; Lin N; Jiang W; Lodi S; Lioznov D; Patts G; Gnatienko N; Blokhina E; Bendiks S; Freiberg MS; Tindle HA; Krupitsky E; Hahn JA; Samet JH; So-Armah K
    J Acquir Immune Defic Syndr; 2023 Nov; 94(3):244-252. PubMed ID: 37850982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
    Tumwegamire A; Fatch R; Emenyonu NI; Lodi S; Muyindike WR; Kekibiina A; Adong J; Ngabirano C; Beesiga B; Marson K; Golabi N; Kamya M; Chamie G; Hahn JA
    PLoS One; 2024; 19(3):e0300508. PubMed ID: 38507431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker-Measured Unhealthy Alcohol Use in Relation to CD4 Count Among Individuals Starting ART in Sub-Saharan Africa.
    Magidson JF; Fatch R; Orrell C; Amanyire G; Haberer JE; Hahn JA;
    AIDS Behav; 2019 Jun; 23(6):1656-1667. PubMed ID: 30560484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heavy Alcohol Use is Associated with Lower CD4 Counts among Russian Women Living with HIV: A Multilevel Analysis.
    Capasso A; Brown JL; Safonova P; Belyakov N; Rassokhin V; DiClemente RJ
    AIDS Behav; 2021 Nov; 25(11):3734-3742. PubMed ID: 34014428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults.
    Fiseha T; Ebrahim H; Ebrahim E; Gebreweld A
    PLoS One; 2022; 17(3):e0265740. PubMed ID: 35324948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapy.
    Kowalski S; Colantuoni E; Lau B; Keruly J; McCaul ME; Hutton HE; Moore RD; Chander G
    J Acquir Immune Defic Syndr; 2012 Dec; 61(4):455-61. PubMed ID: 22955054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study.
    Conen A; Wang Q; Glass TR; Fux CA; Thurnheer MC; Orasch C; Calmy A; Bernasconi E; Vernazza P; Weber R; Bucher HC; Battegay M; Fehr J
    J Acquir Immune Defic Syndr; 2013 Dec; 64(5):472-8. PubMed ID: 23892243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda.
    Bajunirwe F; Haberer JE; Boum Y; Hunt P; Mocello R; Martin JN; Bangsberg DR; Hahn JA
    PLoS One; 2014; 9(12):e113152. PubMed ID: 25436894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylethanol confirmed alcohol use among ART-naïve HIV-infected persons who denied consumption in rural Uganda.
    Muyindike WR; Lloyd-Travaglini C; Fatch R; Emenyonu NI; Adong J; Ngabirano C; Cheng DM; Winter MR; Samet JH; Hahn JA
    AIDS Care; 2017 Nov; 29(11):1442-1447. PubMed ID: 28278568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.
    Le T; Wright EJ; Smith DM; He W; Catano G; Okulicz JF; Young JA; Clark RA; Richman DD; Little SJ; Ahuja SK
    N Engl J Med; 2013 Jan; 368(3):218-30. PubMed ID: 23323898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV-Infected Young Russian Women: Comparison to Self-Report Assessments of Alcohol Use.
    Littlefield AK; Brown JL; DiClemente RJ; Safonova P; Sales JM; Rose ES; Belyakov N; Rassokhin VV
    AIDS Behav; 2017 Jul; 21(7):1938-1949. PubMed ID: 28421353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol use and immune reconstitution among HIV-infected patients on antiretroviral therapy in Nairobi, Kenya.
    Cagle A; McGrath C; Richardson BA; Donovan D; Sakr S; Yatich N; Ngomoa R; Chepngeno Langat A; John-Stewart G; Chung MH
    AIDS Care; 2017 Sep; 29(9):1192-1197. PubMed ID: 28132519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic Status and CD4 Count Among People with HIV Who Inject Drugs in St. Petersburg, Russia.
    Idrisov B; Van Draanen J; Lodi S; Lunze K; Kimmel SD; Quinn EK; Truong V; Blokhina E; Gnatienko N; Krupitsky E; Samet JH; Williams EC
    AIDS Behav; 2024 Jul; 28(7):2239-2246. PubMed ID: 38658481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa.
    Hahn JA; Dobkin LM; Mayanja B; Emenyonu NI; Kigozi IM; Shiboski S; Bangsberg DR; Gnann H; Weinmann W; Wurst FM
    Alcohol Clin Exp Res; 2012 May; 36(5):854-62. PubMed ID: 22150449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort.
    Hahn JA; Cheng DM; Emenyonu NI; Lloyd-Travaglini C; Fatch R; Shade SB; Ngabirano C; Adong J; Bryant K; Muyindike WR; Samet JH
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):492-501. PubMed ID: 29303844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
    Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
    PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ART initiation in an outpatient treatment center in Dakar, Senegal: A retrospective cohort analysis (1998-2015).
    Ngom NF; Faye MA; Ndiaye K; Thiam A; Ndour CT; Etard JF; Sow PS; Seydi M; Delaporte E; Cournil A
    PLoS One; 2018; 13(9):e0202984. PubMed ID: 30231075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size.
    Rasmussen TA; Ahuja SK; Kuwanda L; Vjecha MJ; Hudson F; Lal L; Rhodes A; Chang J; Palmer S; Auberson-Munderi P; Mugerwa H; Wood R; Badal-Faesen S; Pillay S; Mngqibisa R; LaRosa A; Hildago J; Petoumenos K; Chiu C; Lutaakome J; Kitonsa J; Kabaswaga E; Pala P; Ganoza C; Fisher K; Chang C; Lewin SR; Wright EJ
    Clin Infect Dis; 2022 Nov; 75(10):1781-1791. PubMed ID: 35396591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial.
    Freiberg MS; Cheng DM; Gnatienko N; Blokhina E; Coleman SM; Doyle MF; Yaroslavtseva T; Bridden C; So-Armah K; Tracy R; Bryant K; Lioznov D; Krupitsky E; Samet JH
    JAMA Netw Open; 2020 May; 3(5):e204330. PubMed ID: 32383748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.